Now showing items 1-2 of 2
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
BACKGROUND: In phase 2 trials, treatment with the combination of the nucleotide polymerase inhibitor sofosbuvir and the NS5A inhibitor velpatasvir resulted in high rates of sustained virologic response in patients chronically ...
Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.
BACKGROUND & AIMS: Chronic hepatitis B (CHB) infection acquired perinatally or in early childhood has been associated with a prolonged phase of immune tolerance from viral exposure into early adulthood. The immune-tolerant ...